Skip to content
Products
Resources
Company
Virtual lab
Keep in contact
Solid tumor
Blood cancer
Pharmacogenetics
Knowledge hub
Publications
About us
Virtual lab
Careers
Press hub
Contacts
Products
+
Solid tumor
Blood cancer
Pharmacogenetics
Resources
+
Knowledge hub
Publications
Company
+
About us
Virtual lab
Careers
Press hub
Contacts
Virtual lab
Keep in contact
Reserved Area
Publications
Publications
Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.
Filter
Year
All years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2008
Product line
All product lines
Easy
Easy PGX
Helix
Microsatelliti
Myriapod
Myriapod NGS
Realquant
Response
26.06.2018
Myriapod
Iván Prieto Potin et. al, Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer
19.06.2018
Myriapod
Luca Reggiani Bonetti et. al, Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
02.06.2018
Myriapod
Jasna Metovic et. al, Safe transportation of formalin-fixed liquid-free pathology specimens
23.05.2018
Myriapod
Sabrina Arena et. al, Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer
14.05.2018
Response
Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.
06.04.2018
Easy
,
Myriapod
Valeria Maffeis et. al, Onycholemmal carcinoma: A case report with its molecular profiling
27.03.2018
Claudia Rengucci et. al, Stool DNA Integrity Method for Colorectal Cancer Detection
26.03.2018
Easy
Roberta Minari et. al, Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in NSCLC EGFR-mutated patient.
09.03.2018
Response
Lorena Gurrieri et. al, MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme”
31.01.2018
Myriapod
Fabrizio Tabbò et. al, Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma
Previous
Page
1
…
Page
27
Page
28
Page
29
Page
30
Page
31
…
Page
46
Next
Subscribe to Our Newsletter
First name
Last name
Company / Istitution
Country
Email
I confirm that I have read the
information on the personal data management.
I agree to the processing of my personal data according to the above mentioned information
Subscribe
Search
Search